Home Blog Page 834

MSIG Helper Insurance unveils new campaign: ‘Assured Helper, Confident Employer’

By
Advertorial Desk
-

To strengthen MSIG’s leading position in the Helper Insurance market


HONG KONG SAR – Media OutReach Newswire – 23 March 2026 – MSIG Insurance (Hong Kong) Limited (“MSIG”) today announced the launch of its new helper insurance promotional campaign, appointing the esteemed artist, Mr Lam Shing Bun (Bob Lam), as product ambassador. Under the theme “Assured Helper, Confident Employer”, the campaign promotes MSIG Helper Insurance across multiple channels, including television commercials, online videos, outdoor advertising and digital platforms, further cementing the brand’s position as the market leader.

Crafting insurance that delivers shared peace of mind

Philip Kent, Chief Executive Officer of MSIG Hong Kong, stated: “Hong Kong today is home to more than 360,000 foreign domestic helpers, as well as over 20,000 local ‘hourly workers’. As such, there is significant market demand for insurance that specifically caters both to their needs and those of their employers. That’s why we have developed a comprehensive and affordable plan that provides extensive medical coverage for domestic helpers and helps their employers cope with financial burdens associated with illness.

We view helper insurance as one of our flagship offerings and believe it truly embodies our commitment to ‘Assured Helper, Confident Employer’, which is the essence of the campaign. We aim to help the public understand how helper insurance can benefit families and to establish MSIG as the market leader in Hong Kong for this type of insurance.”

Bob Lam set to resonate with viewers

Targeting Hong Kong families as its primary audience, this campaign features the popular celebrity Bob Lam as product ambassador. Bob maintains an active presence across social media and traditional platforms, frequently sharing humorous glimpses into his life with his family of six. His relatable persona has earned him a reputation as an endearing husband and devoted father, aligning with MSIG’s brand ethos. Importantly, as an experienced employer who has long employed domestic helpers, Bob’s first-hand experience significantly enhances the credibility of the product information and strongly resonates with the target audience, making him the ideal ambassador for MSIG’s Helper Insurance.

The campaign video opens with Bob livestreaming from home, seamlessly integrating relatable moments such as his wife prompting him to tackle household chores and netizens asking questions about domestic helpers. This light-hearted, humorous approach captures the everyday realities of employer households, eliciting knowing smiles from viewers while introducing the product’s key features in a natural way:

  1. Comprehensive coverage: Includes outpatient, surgical & hospitalisation, dental, domestic helper liability, service interruption, fidelity guarantee and more
  2. Exceptional value: 2-year premium as low as HK$566 for online applications1
  3. Speedy claims processing: Online claims approval in as fast as 15 minutes
  4. Flexible and adaptable: Suitable for local domestic helpers, post-natal care helpers and home-based elderly carers, accommodating diverse family needs

Multi-channel media campaign to maximise reach

This initiative marks MSIG’s first major promotional campaign for 2026, employing a multi-dimensional media strategy to achieve seamless online and offline coverage. The campaign will be rolled out across television, YouTube, other major social media platforms and digital channels, targeting the intended audience with precision. Outdoor media placements include tram and bus wrap advertising, large-scale billboards in Causeway Bay and digital screens at multiple high-traffic locations. Through this tightly integrated multi-channel network, the campaign will significantly boost brand visibility and message penetration, ensuring the core message of helper insurance is powerfully conveyed to every corner of Hong Kong.


1 Offer applies to designated MSIG Helper Insurance plan, please refer to MSIG website and terms and conditions of relevant product.

Hashtag: #MSIG

The issuer is solely responsible for the content of this announcement.

About MSIG Insurance (Hong Kong) Limited (“MSIG Hong Kong”)

MSIG Hong Kong is a wholly owned subsidiary of Mitsui Sumitomo Insurance Co Ltd and a member of the MS&AD Insurance Group, Asia’s leading general insurance brand with presence in 50 countries and regions globally. The Group is amongst the world’s top 10 insurance groups based on gross revenue and one of Japan’s leading insurers with A+ Stable credit rating. With over 40,000 employees world-wide, MSIG is represented in all ASEAN markets as well as in Australia, New Zealand, Hong Kong, Mainland China, Korea, India and Taiwan.

MSIG Hong Kong offers a wide range of solutions and services through an extensive distribution network including agents, brokers, and bancassurance alliances with leading banks. It has been providing general insurance solutions to customers in Hong Kong for more than 170 years, dating as far back as 1855.

NETMARBLE STEAM PLAYTEST SIGN-UPS UNDERWAY FOR GAME OF THRONES: KINGSROAD

By
Advertorial Desk
-

SEOUL, South Korea, March 23, 2026 /PRNewswire/ — Netmarble, a leading developer and publisher of high-quality games, is currently accepting sign-ups for the upcoming Steam Playtest for Game of Thrones: Kingsroad ahead of its launch in Asia.

Source: Netmarble
Source: Netmarble

Players can apply to participate in the Steam Playtest through the game’s Steam page until April 23, with the test scheduled to run from April 17 to April 24.

Players who take part in the Steam Playtest will be able to experience the vast open world of Westeros, brought to life with unprecedented scale and remarkable detail. Set across the Seven Kingdoms, the game allows players to explore a sprawling open world inspired by the epic saga of the series, offering an early look at immersive environments and action RPG gameplay.

The upcoming test will support multiple languages to accommodate players across the region, including Korean, Japanese, Thai, Traditional Chinese, Simplified Chinese, Russian, and English.

Meanwhile, pre-registration for Game of Thrones: Kingsroad is currently underway with strong player interest. Players who pre-register can receive a range of platform-specific rewards designed to support early progression and customization, including Northern Outfit, mounts, in-game currency, and cosmetic items.

Netmarble is hosting a subscription event across official channels, offering additional rewards such as the launch special title “Harbinger of Westeros” and 100,000 Copper.

Game of Thrones: Kingsroad is an open-world RPG based on HBO®’s iconic Emmy®- and Golden Globe®-winning original drama series, Game of Thrones. The game is officially licensed by Warner Bros. Interactive Entertainment on behalf of HBO.

For the latest updates, visit the official website of Game of Thrones: Kingsroad or check out official social media channels.

GAME OF THRONES: KINGSROAD, GAME OF THRONES, HOUSE OF THE DRAGON and all related characters and elements © & ™ HOME BOX OFFICE, INC. (s26) All rights reserved. ™ & © Warner Bros. Entertainment Inc. (s26)

About Netmarble Corporation

Founded in Korea in 2000, Netmarble Corporation is a leading global game developer and publisher. Through acclaimed franchises and strategic partnerships with top-tier IP holders, the company delivers innovative and engaging gaming experiences to audiences worldwide. As a parent company of Kabam, SpinX Games, Jam City, and a major shareholder of HYBE and NCSOFT, Netmarble’s diverse portfolio includes Solo Leveling:ARISE, Seven Knights Re:BIRTH, and Raven2. More information can be found at http://company.netmarble.com.

Residents Along Laos-China Railway Have Until June to Claim Land Compensation

By
Thongsavanh Souvannasane
-
Vientiane residents must claim railway compensation by June or lose land, as long-running disputes over inadequate payments remain unresolved.

The Vientiane Capital Department of Public Works and Transport has issued a notice calling on residents affected by the Laos-China Railway to come forward and claim compensation for land acquired along the railway corridor, or risk losing it to the state permanently.

The notice, dated 6 March, covers 43 villages across four districts in Vientiane Capital: 24 villages in Naxaythong, eight in Xaythany, nine in Xaysettha, and two in Hatsayfong. 

Affected residents must submit claims in person at the department’s office between 18 March and 18 June, English state media reported on 23 March. Any property whose owner has not come forward by the deadline will be transferred and reclassified as state property.

The announcement comes years after the railway first displaced thousands of families across Laos. The USD 6 billion project, built as part of China’s Belt and Road Initiative and opened in December 2021, affected an estimated 6,875 families nationwide. 

As of late 2024, at least 371 families had still not received full compensation, having refused what they described as inadequate offers. The government had by that point already paid USD 83 million to 6,504 of the affected families.

Compensation disputes have dogged the project for years. Many residents along the corridor say the rates they were offered fell well short of their land’s market value and have refused to settle.

The railway itself has been a transformative project for Laos. 

The 414-kilometre line links Vientiane to the Chinese border at Boten and has carried more than 62 million passengers since opening. It forms part of the broader Kunming-Singapore rail corridor plan and remains the most significant Belt and Road project in the country.

For residents still waiting, the June deadline marks the last chapter of the compensation process. Authorities have urged all eligible parties to act promptly.

Cathay Pacific Expands Global Partnership with Adyen

By
Advertorial Desk
-

Adyen’s direct acquiring solution boosts performance for Hong Kong’s home carrier in the world’s most dynamic markets

SINGAPORE – Media OutReach Newswire – 23 March 2026 – Adyen, the global financial technology platform of choice for leading businesses, today announced the expansion of its longstanding partnership with Cathay Pacific, Hong Kong’s home airline. This deepening of collaboration marks a significant milestone, with Adyen now providing direct acquiring services for the airline in markets including Hong Kong, Australia, New Zealand, the United States, Japan, and most recently, India.

Adyen’s partnership with Cathay Pacific, which began in 2014, has evolved from its initial scope to become a core component of the airline’s global commerce strategy. With the successful implementation of direct acquiring in Cathay Pacific’s key markets, this expansion underscores Adyen’s role as a strategic growth partner, using direct acquiring capabilities to increase authorization rates, reduce payment fees, and unlock new revenue.
Notably with the recent roll-out in India, Adyen’s acquiring solution ensures performance. Since implementation, Cathay Pacific achieved a 10% increase in authorization rates in the market.
“At Cathay Pacific, we believe that a seamless and trusted shopping experience is essential to elevating ourselves to become the most loved service brand of our customers,” said Kinto Chan, General Manager, Sales and Distribution, Cathay Pacific. “By leveraging Adyen’s single integration and trusted extensive global acquiring network, we can ensure our customers transact securely while allowing us to expand into our target markets with ease.”

“Our partnership with Cathay Pacific is centered on turning global payment complexity into a competitive advantage,” said Warren Hayashi, President, Asia Pacific, Adyen. “By optimizing authorization rates across diverse geographies, we ensure more bookings take flight, helping Cathay achieve commercial growth on a global stage.”

Hashtag: #ADYEN #CATHAYPACIFIC #PAYMENTS #TRAVEL #RETAIL #PAYMENTTECHNOLOGY #ENTERPRISETECHNOLOGY


The issuer is solely responsible for the content of this announcement.

About Adyen

Adyen (AMS: ADYEN) is the financial technology platform of choice for leading companies. By providing end-to-end payments capabilities, data-driven insights, and financial products in a single global solution, Adyen helps businesses achieve their ambitions faster. With offices around the world, Adyen works with the likes of Meta, LVMH, SHEIN, Uber,L’Oréal, Cathay Pacific, Grab, Klook, and Singapore Airlines. The cooperation with Cathay Pacific as described in this merchant update underlines Adyen’s continuous growth with current and new merchants
over the years.

About Cathay Pacific

Premium full-service airline Cathay Pacific is the home carrier of Hong Kong with eight decades of history, and is a founding member of the oneworld global alliance. Cathay Pacific is part of the Cathay Group, which also comprises the cargo division Cathay Cargo, low-cost carrier HK Express, and its lifestyle business Cathay Lifestyle. Cathay is a member of the Swire Group and is listed on the Hong Kong Stock Exchange (HKSE). For more information, please visit www.cathaypacific.com.

Partnership Paves the Way Forward

By
Advertorial Desk
-

BELGRADE, Serbia, March 23, 2026 /PRNewswire/ — Roads serve as vital connections for regional development and serve as a cornerstone for improving people’s lives. In recent years, as Serbia advances its modernization drive, POWERCHINA has been deeply engaged in the country’s infrastructure projects, including highways, metro lines and tunnels. These efforts ensure that the fruits of collaborative development deliver tangible benefits to the local people.

In 2017, POWERCHINA launched its first project in Serbia, a section of the Belgrade Bypass Highway, Phase II. As a key cross-border transport hub in Europe, Belgrade had long been plagued by severe traffic congestion. Upon completion, the bypass diverts traffic around the urban periphery, significantly easing downtown traffic congestion and cutting commute times. Beyond improving daily travel for local citizens, the project established POWERCHINA as a professional and reliable partner in the Serbian market, laying a solid foundation for future cooperation.

Building on the success of its highway projects, POWERCHINA went on to participate in the construction of Belgrade’s Metro Line 1, a landmark project first envisioned half a century ago. Securing this contract underscored POWERCHINA’s nearly 15 years of commitment to the Serbian market, where consistent delivery and professional expertise have earned broad trust. To address the complex geological conditions of metro construction, the company deployed mature tunnel boring machine (TBM) technologies refined through nearly two decades of global practice. These solutions not only ensure construction safety and efficiency but also facilitate knowledge transfer to local teams. The technologies can also be applied to mountain tunnels and other infrastructure, providing long-term technical support for local development.

For the Karadjordjevo-Danube Slope Tunnel project, a TBM shield was used for the first time in a Serbian road tunnel, boosting daily excavation from just 2 meters to 15 meters, a major leap in productivity. Chinese and Serbian employees work side by side, deepening mutual understanding and building trust through daily collaboration. Every completed project is a testament to technology transfer and talent development, cultivating local teams that combine Chinese expertise with European standards.

From improving public transport to realizing urban visions, from sharing technology to developing local talent, POWERCHINA continues to prioritize local needs and foster mutually beneficial partnerships in Serbia. Guided by mutual learning and common goals, the two sides are stepping forward together toward a brighter, shared future. Watch the video to learn more.

YouTube：https://www.youtube.com/watch?v=CzhXm0Of51A

Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize CARDAMYST™ (Etripamil) Nasal Spray in Greater China

By
Advertorial Desk
-

SHANGHAI, March 23, 2026 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Hong Kong Limited (“CORXEL”). Under the agreement, the Company has acquired the rights to develop, manufacture, and commercialize CARDAMYST™ (etripamil) nasal spray in Greater China, including Chinese Mainland, Hong Kong, Macao and Taiwan region.

Under the terms of the agreement, Everest will pay CORXEL an upfront payment of US$30 million (equivalent to approximately RMB344,895,000), as well as potential development milestone payments of up to US$20 million (equivalent to approximately RMB137,958,000). As part of this agreement, Everest will be assigned and transferred rights, interests, claims, duties, obligations and liabilities (other than certain excluded liabilities) under the Milestone License Agreement entered into by CORXEL in May 2021 and certain related ancillary agreements.

CARDAMYST™ (etripamil) nasal spray is a novel, rapid-acting calcium channel blocker as administered as needed via a convenient, portable nasal spray. It offers rapid onset of action, favorable tolerability, and the potential for at-home self-administration, enhancing patient accessibility. In December 2025, CARDAMYST was approved by the U.S. Food and Drug Administration (FDA), becoming the first and only self-administered nasal spray in more than 30 years capable of converting paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. As a rapid-acting treatment option, CARDAMYST can be self-administered outside the emergency department or other healthcare settings, enabling patients to actively manage episodes and gain greater control over their condition. In addition to its approved indication for PSVT, etripamil nasal spray is also under clinical development for atrial fibrillation with rapid ventricular response (AFib-RVR). Phase II trials have shown encouraging results, and Phase III trials are planned, with the potential to further extend its therapeutic impact to a broader patient population.

In China, the New Drug Application (NDA) for etripamil nasal spray was accepted by the National Medical Products Administration (NMPA) on January 17, 2025 and is expected to receive approval in the third quarter of 2026.

PSVT is characterized by abnormalities in the heart’s electrical system that cause sudden unexpected and often severely symptomatic episodes of rapid heart rate. There are currently no approved self-administered, fast-acting, non-injectable therapies for acute PSVT, leaving patients with limited treatment options beyond emergency care. Approximately 2.3 to 4 per 1,000 individuals are affected by PSVT, representing an estimated 3 to 6 million patients in China.

AFib-RVR is a type of irregular heart rhythm, characterized by an irregular and elevated heart rate. Its onset is typically gradual, episodes are less likely to terminate spontaneously, and the condition tends to recur, significantly increasing the risk of thromboembolism and serious complications such as stroke and heart failure. In China, atrial fibrillation affects an estimated 1.6% of the population, representing nearly 20 million patients, and is expected to increase with an aging population. Both PSVT and AFib-RVR are associated with a loss of control and a significant psychological burden for patients.

Driven by its 2030 Strategy, and led by Mr. Yifang Wu, Chairman of the Board, Everest is accelerating growth through a dual-engine approach that combines strategic business development partnerships with in-house R&D. This transaction further strengthens Everest’s expanding cardiovascular franchise, building on recent strategic initiatives and reinforcing the Company’s disciplined approach to constructing focused therapeutic verticals with meaningful lifecycle expansion potential. Through continued advancement of its pipeline and product portfolio globally, Everest aims to deliver innovative therapies to more patients, create sustainable long-term value, and advance its position to become a leading global biopharmaceutical company.

“We are pleased to collaborate with CORXEL, this agreement marks an important step in our continued expansion in the cardiovascular field and a meaningful milestone in advancing our growth 2030 strategy,” said Mr. Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “PSVT is a large and significantly underserved market in China, with no fast-acting, non-injectable, self-administered therapies approved for the acute treatment of PSVT. CARDAMYST provides an innovative on-demand treatment option that empowers patients to manage episodes anytime and anywhere. It is currently the only therapy designed for at-home self-administration to enable the acute termination of PSVT and AFib-RVR episodes, addressing a significant unmet medical need among patients in China. We will leverage our clinical development expertise and established commercialization platform to accelerate its advancement and future launch in Greater China, while further strengthening our cardiovascular franchise and unlocking its broader potential across atrial arrhythmias.”

“Since acquiring the rights to develop and commercialize etripamil nasal spray in 2021 in Greater China, CORXEL has quickly rolled out its clinical development program and submitted its NDA application following positive topline data from the China Phase 3 trial for treating PSVT. This demonstrates CORXEL’s strong execution capability in developing innovative medicines with speed and quality,” said Ms. Sandy Mou, Board Executive Director and Chief Executive Officer of CORXEL. “We are pleased with the purchase agreement with Everest Medicines，and are confident that Everest, with its deep expertise in cardiovascular therapeutics and strong commercialization capabilities, is the ideal partner to successfully bring etripamil nasal spray to clinical practice and benefit patients in China. This agreement also allows CORXEL to further focus its resources on advancing the global development of its core pipeline.”

The NDA for etripamil nasal spray was accepted by the NMPA based on data from the pivotal global Phase 3 RAPID study and the China Phase 3 JX02002 study. Both trials met their primary endpoints. In the JX02002 study, a greater number of patients receiving etripamil achieved the conversion to sinus rate within 30 minutes, compared with placebo (hazard ratio [HR] = 3.02; p=0.0005). Overall, the treatment emergent adverse events (TEAEs) were comparable between the etripamil and placebo groups. Notably, no serious adverse events (SAEs) were reported within 24 hours of etripamil administration in either Phase 3 trial. 

The FDA approval of CARDAMYST was supported by a robust clinical program that included safety data from more than 1,800 participants across more than 2,000 PSVT episodes. This included the Phase 3 RAPID trial, a global, randomized, double-blind comparison of etripamil versus placebo, published in The Lancet in 2023. The RAPID trial achieved its primary endpoint, with 64% of participants who self-administered etripamil (N=99) converting from supraventricular tachycardia (SVT) to sinus rhythm within 30 minutes compared with 31% on placebo (N=85) (HR = 2.62; p<0.001). The median time to conversion was 17 minutes (95% CI: 13.4, 26.5) for etripamil versus 54 minutes (95% CI: 38.7, 87.3) for placebo. The most common adverse events (≥5%) were generally mild-to-moderate and transient in nature, including local-site nasal discomfort, nasal congestion, rhinorrhea, throat irritation, and epistaxis. Fewer than 2% of participants discontinued therapy due to adverse events. 

Etripamil nasal spray is also under clinical development for AFib-RVR. In the randomized, controlled Phase 2 ReVeRA study, etripamil demonstrated rapid and significant reduction in ventricular rate in patients with AFib‑RVR, achieving its primary endpoint. A greater number of patients receiving etripamil achieved a ventricular rate of less than 100 bpm (58.3%) than those receiving placebo (4%). The safety profile was consistent with previous studies.

About CARDAMYST™（etripamil) Nasal Spray

Etripamil is a novel calcium channel blocker developed by Milestone Pharmaceuticals Inc. (Nasdaq: MIST). It is designed as a rapid-response therapy for episodic cardiovascular conditions. As a self-administered nasal spray, etripamil has the potential to shift treatment from emergency department-based care to a patient-managed setting. In May 2021, JIXING (now CORXEL) and Milestone entered into an exclusive license agreement for the development and commercialization of investigational drug etripamil for PSVT and other cardiovascular indications in Greater China (“Milestone License Agreement”).  

About Everest Medicines

Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative pharmaceutical products that address critical unmet medical needs for patients in global markets. The management team of Everest Medicines has deep expertise and an extensive track record both in China and with leading global pharmaceutical companies.

The Company’s therapeutic areas of focus include autoimmune, ophthalmology, critical care, and CKM (cardiovascular, kidney, and metabolic) diseases. Everest Medicines has developed a fully integrated commercialization platform that combines omnichannel commercial capabilities with end-to-end product lifecycle management. Leveraging its proprietary mRNA platform, the Company is advancing its existing pipeline, including mRNA in vivo CAR-T and mRNA cancer vaccines, while selectively expanding into additional high-value therapeutic areas with blockbuster potential, and accelerating its global expansion. For more information, please visit the Company’s website: www.everestmedicines.com.

About CORXEL

CORXEL is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients with cardiometabolic conditions around the world. CORXEL is led by an experienced management team that has a strong track record of identifying, in-licensing and developing attractive clinical product candidates directed at validated targets with proven mechanisms of action (MoAs). CORXEL’s diverse portfolio of clinical-stage product candidates has the potential to redefine treatment standards and address key limitations of current therapies for multiple cardiometabolic indications. CORXEL is developing selective small molecule compounds across the cardiometabolic spectrum with the lead product candidate CX11, an oral small molecule GLP-1 RA under clinical development for obesity and overweight conditions and T2DM, JX10, a thrombolytic and anti-inflammatory agent for acute ischemic stroke and CX12, an oral small molecule amylin RA under pre-clinical development. CORXEL also has additional small molecule programs in development targeting validated obesity targets. 

For further information about CORXEL, please visit www.corxelbio.com 

Forward-Looking Statements

This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law.

Singapore cybersecurity firms showcase SME-focused innovations to counter rising cyber threats at RSAC 2026 Conference

By
Advertorial Desk
-

SINGAPORE – Media OutReach Newswire – 23 March 2026 – As cyber threats intensify globally, the World Economic Forum (WEF) projects that the global economic impact of cyberattacks will surge from US$8.44 trillion in 2022 to US$23.84 trillion by 2027[1], exposing a widening gap between escalating risk and cyber readiness.

Small and medium-sized enterprises (SMEs), which form the backbone of most economies, are particularly vulnerable. The WEF’s 2024 Global Cybersecurity Outlook[2]highlights that limited access to cyber services, tools and skilled talent continues to hinder smaller organisations from achieving even baseline resilience, an increasingly urgent concern in today’s highly interconnected digital ecosystem. As a result, SMEs are often more exposed to common risks such as accidental data leaks and unpatched vulnerabilities in the software and open‑source components used to build modern digital applications.

To help address these challenges, three homegrown companies from Singapore, AgileMark, Scantist and StrongKeep are pioneering technologies that make cybersecurity more accessible and effective for businesses, including SMEs without dedicated security teams. Their solutions focus on strengthening data loss protection and mitigating risks from human behaviours like screen photography and unsafe network use, uncovering hidden vulnerabilities in software systems, and simplifying the adoption of essential security measures through easy-to-deploy platforms.

These companies are supported by the S$20 million CyberSG Talent, Innovation and Growth Collaboration Centre (TIG Centre), a joint initiative between the National University of Singapore (NUS) and the Cyber Security Agency of Singapore (CSA). The TIG Centre works closely with cybersecurity companies and start-ups to co-develop solutions that help organisations stay ahead of emerging threats while enabling the safe and confident adoption of new technologies.

“Many businesses today, especially SMEs, face escalating cyber risks but often lack the resources to protect themselves effectively. In Singapore, online scams and ransomware attacks continue to be key concerns. At the same time, advances in AI are transforming both cyber threats and cybersecurity and rapidly expanding the attack surface of enterprises. Through the CyberSG Talent, Innovation and Growth Collaboration Centre, we support innovators developing practical solutions to address these challenges, and bring Singapore’s most promising cybersecurity start-ups to the global stage at the RSAC 2026 Conference,” said Mr Willis Lim, Executive Director, TIG Centre.

AgileMark: Preventing data leaks caused by everyday human actions

Many data exposure incidents stem not from sophisticated cyberattacks, but from routine behaviours such as photographing screens, copying sensitive documents or working in unsecured environments.

AgileMark mitigates this risk by introducing visible, dynamic watermarks on corporate screens. These act as behavioural cues to deter unauthorised capture, reinforce employee awareness of data sensitivity, and enable traceability if leaks occur. Designed with a human-first approach, it addresses the reality many SMEs face: limited time, resources and expertise to manage complex tools. By focusing on user behaviour rather than adding new systems, it reduces risk without increasing operational burden. Today, AgileMark protects over 300,000 devices globally, reducing investigation time from weeks to hours and enabling faster response to potential data breaches.

Scantist: Finding security flaws in software before hackers do

As organisations accelerate software development, greater reliance on open-source components and third-party dependencies has increased exposure to supply chain risks and hard-to-detect vulnerabilities.

Scantist provides an AI-powered application security platform that helps organisations manage open-source, software supply chain and AI-related risks across the development lifecycle, from code to deployment. Complementing its defensive capabilities, Scantist also offers an autonomous, agentic penetration testing solution that simulates attacker behaviour, enabling more frequent testing and reducing assessment timelines from days to hours. For SMEs in particular, Scantist makes advanced security testing and risk management more accessible without requiring large in-house security teams, helping businesses strengthen resilience and keep pace with evolving threats in a cost-effective, scalable manner.

StrongKeep: Making cybersecurity simpler and more affordable for SMEs

Many SMEs face barriers to adopting cybersecurity tools due to cost, complexity and the need for specialised expertise.

StrongKeep addresses this challenge with an all-in-one cybersecurity platform tailored for SMEs. The platform integrates essential protections such as device security, website filtering, phishing awareness training and password management into a single, easy-to-use system. Organisations can deploy the platform and begin protecting their systems in under 60 minutes, even without dedicated cybersecurity staff. With subscriptions starting from S$39 per month, the solution enables SMEs to achieve comprehensive protection and compliance up to 10 times faster than traditional approaches.

Showcasing Singapore’s cybersecurity solutions at the RSAC Conference 2026

AgileMark, Scantist and StrongKeep are among eight TIG Centre-supported companies that will showcase their solutions at Singapore’s national pavilion at the RSAC 2026 Conference, held from 23 to 26 March 2026 at the Moscone Center in San Francisco, United States.

Organised by the TIG Centre and SGTech, the leading trade association for Singapore’s tech industry, the Singapore Pavilion underscores Singapore’s role as a cybersecurity innovation hub and a strategic gateway to Asia’s rapidly expanding digital economy.

Hashtag: #cybersecurity #singaporecybersme #CybersgTIG #nusenterprise #NUS


The issuer is solely responsible for the content of this announcement.

National University of Singapore (NUS)

The National University of Singapore (NUS) is Singapore’s flagship university, which offers a global approach to education, research and entrepreneurship, with a focus on Asian perspectives and expertise. We have 16 colleges, faculties and schools across three campuses in Singapore, with more than 40,000 students from 100 countries enriching our vibrant and diverse campus community. We have also established more than 20 NUS Overseas Colleges entrepreneurial hubs around the world.

Our multidisciplinary and real-world approach to education, research and entrepreneurship enables us to work closely with industry, governments and academia to address crucial and complex issues relevant to Asia and the world. Researchers in our faculties, research centres of excellence, corporate labs and more than 30 university-level research institutes focus on themes that include energy; environmental and urban sustainability; treatment and prevention of diseases; active ageing; advanced materials; risk management and resilience of financial systems; Asian studies; and Smart Nation capabilities such as artificial intelligence, data science, operations research and cybersecurity.

For more information on NUS, please visit .

NUS Enterprise

At NUS Enterprise, the entrepreneurial heart of the National University of Singapore (NUS), we advance the University as a global magnet for talent and an engine for impactful innovation. We seed ideas, spark innovation, and scale ventures through our distinctive 360° framework, integrating education, ecosystem support, and world-class venture building and investment.

This creates a self-reinforcing cycle powering both educational and entrepreneurial outcomes across industries and communities. Since 2001, NUS Enterprise has nurtured 10 unicorns, over 3,000 start-ups, and 4,300 students. Our ambition: to improve the lives of 1 billion people by 2035.

For more information on NUS Enterprise, please visit .

The CyberSG Talent, Innovation and Growth Collaboration Centre

The CyberSG Talent, Innovation and Growth Collaboration Centre, established by the Cyber Security Agency of Singapore (CSA) in partnership with the National University of Singapore (NUS), will play a key role in achieving a comprehensive approach to ecosystem development which consolidates and enhances CSA’s existing talent and innovation initiatives. The Centre will enable synergies between cybersecurity talent, innovation and growth industry, by serving as a national node to integrate and create relevant programmes for industry and talent development. It will help build a vibrant cybersecurity ecosystem by bring together industry, academia, individual and government stakeholders to leverage the opportunities posed by digitalisation.

ART CENTRAL AND ITS ESTEEMED PARTNERS PRESENT DIVERSE ARTIST PROJECTS AND EXCEPTIONAL HOSPITALITY EXPERIENCES

By
Advertorial Desk
-

UOB SPOTLIGHTS LARGE‑SCALE INK INSTALLATION ART
EVOLVING FROM MICROSCOPIC LIFE IMAGERY

Discover three Macao Artist Presentations by Sands China

MTN Seni Budaya Showcases Eight Galleries Defining Indonesian Contemporary Art

Black Sheep Sets the Table for Exceptional Hospitality at Eat Central

HONG KONG, March 23, 2026 /PRNewswire/ — Art Central, together with Lead Partner UOB, announces today details of the creative projects supported by its partners alongside hospitality presented at the Fair’s eleventh edition. In addition to an exceptional showcase of 117 galleries and more than 500 artists from Hong Kong, Asia, and around the world, Art Central’s expanded suite of artistic presentations, cultural activations, and visitor-focused initiatives together elevate the Fair experience across all touchpoints. A cornerstone of Hong Kong Art Month, Art Central 2026 will be held from 25 to 29 March, with a VIP Preview on 24 March, at its iconic Central Harbourfront location. Art Central 2026 is financially supported by the Mega Arts and Cultural Event Fund under the Culture, Sports and Tourism Bureau of the Hong Kong Special Administrative Region Government.

Presented at Art Central 2026, UOB Art Space: Ling Pui Sze, White Mirror – The Vista of the Inner Worlds (2026), large-scale ink installation. Courtesy of UOB.
Presented at Art Central 2026, UOB Art Space: Ling Pui Sze, White Mirror – The Vista of the Inner Worlds (2026), large-scale ink installation. Courtesy of UOB.

ANNOUNCEMENTS

  • UOB unveils a newly commissioned installation by Hong Kong artist Ling Pui Sze, White Mirror – The Vista of the Inner Worlds (2026).
  • Sands China debuts a showcase of contemporary Macao artists, spotlighting the practices of Lei Ieng Wai, Leong Chi Mou, and Lio Hak Man.
  • MTN Seni Budaya introduces ‘Rising Currents’, showcasing eight galleries at the forefront of Indonesia’s contemporary art discourse.
  • The Fair unveils its signature hospitality offerings from Black Sheep, Soho House Hong Kong, Kronenbourg 1664, and Illy

UOB PRESENTS A CROSS-DISCIPLINARY ENCOUNTER WITH CONTEMPORARY INK PRACTICES

Lead Partner of Art Central, UOB, presents a newly commissioned large-scale installation by Hong Kong artist Ling Pui Sze, titled White Mirror – The Vista of the Inner Worlds (2026). Drawing on Ling’s visual study of cellular imagery and informed by recent scientific research conducted at the University of Cambridge, the work takes the form of an immersive sculptural garden. Ling’s largest installation to date, it comprises a constellation of hand-made paper sculptures and moving images, reflecting her accomplished command of ink, paper and site-making practices. Conceived as a serene, meditative environment evoking both a cosmic landscape and a Zen-garden-like setting, the installation offers a moment of stillness amid the vibrancy of the art fair.

The space is populated by abstract, radiating sculptural forms inspired by neurons — cells responsible for information transmission within the nervous system — interwoven with collaged cellular patterns and projected footage of cellular movement. By magnifying microscopic landscapes into a walkable environment, White Mirror – The Vista of Inner Worlds invites reflection on the interconnectedness of body, mind and external reality. Proposing a sense of kinship between the microcosmic and the cosmic, the work echoes the Daoist notion of “Everything as One”, offering an imaginative yet contemplative site for introspection.

Visitors can also explore dedicated exhibition spaces, featuring works from the 2025 UOB Art in Ink Awards Winners’ Showcase and the UOB Painting of the Year Artist Showcase at the UOB Art Space. Together, these presentations underscore UOB’s commitment to nurturing artistic talent across Hong Kong, mainland China, and Southeast Asia, while fostering cross‑cultural dialogue through contemporary ink and mixed‑media practices.

Extending the experience beyond exhibitions, UOB, in collaboration with the UOB Art Academy, a registered charity in Hong Kong, will present a series of UOB Art in Ink Workshops. Led by established Hong Kong artists Eric Ho, Ling Pui Sze, Tony Ng Kwun Lun, Professor Tong Kam Tang, Professor Yau Wing Fung, and Stephanie Yeung Chung Nga, the workshops bridge traditional ink techniques with contemporary artistic expressions, guiding participants to explore the evolving language of ink art. Pre-registration is required via www.uobartacademy.com.hk/ws2026.

At the Central Theatre, UOB will host the public talk ‘Reading the Unreadable: When Words Become Images’, an in-depth conversation examining how written language shifts into visual, conceptual, and interdisciplinary forms within contemporary art.

Adaline Zheng, CEO of UOB Hong Kong, said, “Marking the 10th anniversary of UOB’s partnership with Art Central, this programme underscores the Bank’s long-term commitment to advancing artistic practice, supporting art education, strengthening cultural connectivity and contributing to social sustainability within Hong Kong’s cultural ecosystem. Through our partnership with Art Central, we will continue to build a platform that evolves alongside Hong Kong’s creative community and connects local artistic practice with the wider regional context.”

SANDS CHINA DEBUTS A SHOWCASE OF CONTEMPORARY MACAO ARTISTS

Sands China makes its debut at Hong Kong Art Month as the Associate Partner of Art Central, marking the first participation of a Macao-based integrated tourism and leisure enterprise at the Fair. Sands Gallery presents works by three contemporary Macao artists, foregrounding the city’s new wave of artistic talent:

  • Lei Ieng Wai draws creative inspiration from the tension between light and shadow in everyday life. He draws on scientific theory as the foundation of aesthetics, transforming artificial spectra, proportional values, and geometric structures into repetitive and precise blocks of colour and surfaces of light, exploring urban changes and the lives of city dwellers.
  • Leong Chi Mou‘s works span painting and installation. His practice interrogates shifting notions of value and the cultural interfaces that shape identity, informed by personal migration histories and Macao’s post-colonial context. Through these inquiries, Leong’s works examine the conditions of cultural survival and the intricate entanglements between artistic essence and value systems.
  • Dor Lio Hak Man channels influences from Japanese manga and Western painting into a practice grounded in everyday observation. His work records daily encounters, emotional impressions, and imaginative associations with a relaxed sensibility. He shapes a refined, philosophically attuned visual language that bridges interior experience with an outward-facing openness.

The Sands Gallery booth also incorporates aesthetic elements of Macao’s century-old firecracker industry, enabling international audiences to trace the city’s cultural development from vernacular craftsmanship to contemporary art expression, while experiencing the city’s rich art and culture landscape shaped by its East–West cultural fusion.

MTN SENI BUDAYA PRESENTS THE CURATED CONSTELLATION ‘RISING CURRENTS’

Contemporary art in Indonesia today unfolds as a manifold practice in motion, where historical reflection and material intelligence intersect with the complexities of contemporary urban life. Its ecosystem grows from critical discourse and emerging sensibilities that continually inform and reshape one another. Art Central partners with Indonesia’s National Talent Management for Arts and Culture (MTN Seni Budaya) to present ‘Rising Currents‘, a curated constellation of eight leading Indonesian galleries: EDSU house, Galeri Ruang Dini, ISA Art Gallery, Puri Art Gallery, RUCI Art Space, SAL PROJECT, SEWU SATU, and V&V.

Rather than advancing a single narrative, ‘Rising Currents’ maps the multiple registers and interconnected dialogues that define Indonesian art at the present moment: from research-based and institutionally grounded practices to emergent experimentation and new visual languages shaped by younger generations. Together, these practices reveal an art scene in motion—deepening its discourse and asserting its position within global contemporary conversations.

MTN Seni Budaya will also host the talk ‘Rising Currents: Indonesian Contemporary Art in Motion’ on 26 March. This conversation examines how Indonesia’s contemporary art ecosystem evolves through diverse artistic practices, gallery infrastructures, and socially engaged perspectives, reflecting on how creative expressions from the region are expanding their presence and dialogue within the global art landscape.

EAT CENTRAL BY BLACK SHEEP

Black Sheep returns to Art Central for the third consecutive year as the Fair’s hospitality partner, unveiling an expanded and much‑anticipated edition of Eat Central. This edition features a new, exciting lineup gathering five of Black Sheep’s most beloved restaurants under one roof, including Cantonese signatures from Ho Lee Fook, a heart‑warming Greek taverna menu from Artemis & Apollo, French favourites from Jean‑Pierre, Neo‑Neapolitan fare and speciality drinks from FALCONE, and sweet scoops from Messina, Hong Kong’s favourite gelato.

EXCEPTIONAL BEVERAGES AT ART CENTRAL

Soho House Hong Kong returns to Art Central with its pop‑up bar, set against a mural by Hong Kong‑based French artists Faustine Badrichani and Elsa Jeannedieu.

The bar will serve a focused cocktail menu featuring classics such as the Picante and the newly launched Highball Fifty, created to celebrate the opening of Soho House Tokyo, the private member club’s 50th House globally, alongside a selection of House favourites perfect for easy afternoons and post‑fair unwinding.

Kronenbourg 1664 joins Art Central 2026 with ‘The Blue Perspective’, an immersive lounge that transforms the experience of enjoying a premium French beer into a curated sensory moment. With a bar concept shaped by 1664 Blanc and the liminal glow of the blue hour—the luminous threshold between day and night—the space invites visitors to slow their pace, settle into conversation, and savour 1664’s crisp, citrus‑bright profile.

The global coffee brand illycaffè marks its third year at Art Central, introducing the latest illy Art Collection by John Armleder. Armleder is renowned for his explorations of perception, reception, and the relationships between artworks and their surroundings, and brings this creative sensibility to ‘Tastes’, a series of cups and saucers that mirror the reflective, shimmering effects of his celebrated light fixtures. Motifs from Armleder’s collection also adorn the illycaffè spaces at the Fair, where an atmosphere of art converges with the excellence of illy’s signature blend, offering visitors a moment of pause and pleasure.

SEAMLESS TRANSIT WITH UBER TAXI

To further enhance the Fair experience, Art Central partners with Uber Taxi this year to offer guests a smooth and comfortable way to travel. With every ride just a tap away—whether crossing the harbour or moving between the city’s cultural districts—visitors can enjoy seamless, point‑to‑point journeys and a stress‑free arrival at the Fair, setting the tone for an unhurried, fully attentive encounter with contemporary art.

Tickets to Art Central are now available. Visitors are encouraged to book online in advance at artcentralhongkong.com/tickets/.

Opening Dates and Hours

Tuesday 24 March
VIP Preview (by invitation) 

Wednesday 25 March
Fair Hours                        12 pm – 5 pm
Night Central                    5 pm – 9 pm 

Thursday 26 March
Fair Hours                        12 pm – 7 pm 

Friday 27 March
Fair Hours                        12 pm – 7 pm 

Saturday 28 March
Fair Hours                        11 am – 7 pm 

Sunday 29 March
Fair Hours                        11 am – 5 pm

Venue

Central Harbourfront Hong Kong, 9 Lung Wo Road

-END-

www.artcentralhongkong.com
Facebook: artcentralhk | Instagram: @artcentralhk |
WeChat Public Platform: artcentral | Xiaohongshu: ArtCentralHK

#ArtCentralHK #ArtCentralUOB #HongKongArtWeek

For media enquiries, please contact:
Chance Communications
[Mandy Chan | mandy@chancecomm.com | 2509 3123][Tommy Yuen | tommy@chancecomm.com | 2509 3389]

About Art Central

Art Central, a cornerstone event of Hong Kong Art Month, presents the next generation of talent from Asia’s most forward-thinking galleries alongside celebrated artists from across the globe. Since its inaugural edition in 2015, Art Central has established itself as a leading platform for innovation in contemporary art, advancing the profiles of artists and galleries and reinforcing their presence within the international art landscape. Today, the Fair is recognised for the strength of its curatorial programming and as a vital meeting point for discovery and exchange among collectors and curators representing private, corporate, and institutional collections worldwide.

Fair Director

Corey Andrew Barr joined Art Central in 2019 with over two decades of experience in the contemporary art world. He previously served as Director at a prominent Hong Kong- and London-based gallery focusing on contemporary Asian art, and as Specialist and Head of Sales at Phillips in New York, where he organised exhibitions featuring leading international artists. Barr has played a key role in expanding Art Central’s platform and reinforcing Hong Kong’s status as Asia’s leading commercial hub for contemporary art. Based in Hong Kong since 2013, Barr is recognised for his commitment to fostering regional and global art connections.

About UOB

UOB is a leading bank in Asia. Operating through its head office in Singapore and banking subsidiaries in China, Indonesia, Malaysia, Thailand and Vietnam, UOB has a global network of more than 470 branches and offices in 19 markets in Asia Pacific, Europe and North America. Since its incorporation in 1935, UOB has grown organically and through a series of strategic acquisitions. Today, UOB is rated among the world’s top banks: Aa1 by Moody’s Investors Service and AA- by both S&P Global Ratings and Fitch Ratings.

For nine decades, UOB has adopted a customer-centric approach to create long-term value by staying relevant through its enterprising spirit and doing right by its customers. UOB is focused on building the future of ASEAN – for the people and businesses within, and connecting with, ASEAN.

The Bank connects businesses to opportunities in the region with its unparalleled regional footprint and leverages data and insights to innovate and create personalised banking experiences and solutions catering to each customer’s unique needs and evolving preferences. UOB is also committed to helping businesses forge a sustainable future, by fostering social inclusiveness, creating positive environmental impact and pursuing economic progress. UOB believes in being a responsible financial services provider and is steadfast in its support of art, social development of children and education, doing right by its communities and stakeholders.

About Sands China Ltd.

Sands China Ltd. (Sands China or the Company) is incorporated in the Cayman Islands with limited liability and is listed on The Stock Exchange of Hong Kong Limited (HKEx: 1928). Sands China is the largest operator of integrated resorts in Macao. The Company’s integrated resorts on the Cotai Strip comprise The Venetian® Macao, The Plaza® Macao, The Parisian® Macao and The Londoner® Macao. The Company also owns and operates Sands® Macao on the Macao peninsula. The Company’s portfolio features a diversified mix of leisure and business attractions and transportation operations, including large meeting and convention facilities; a wide range of restaurants; shopping malls; world-class entertainment at The Venetian Arena, The Londoner Arena, The Venetian Theatre, The Parisian Theatre, the Londoner Theatre and the Sands Theatre; and a high-speed Cotai Water Jet ferry service between Hong Kong and Macao. The Company’s Cotai Strip portfolio has the goal of contributing to Macao’s transformation into a world centre of tourism and leisure. Sands China is a subsidiary of global resort developer Las Vegas Sands Corp. (NYSE: LVS).

About National Talent Management for Arts and Culture

The National Talent Management for Arts and Culture (MTN Seni Budaya) is a program managed by the Ministry of Culture of the Republic of Indonesia, dedicated to identifying, nurturing, and promoting Indonesian creative talents. By facilitating sustainable talent development and international exposure, the National Talent Management for Arts and Culture works to elevate Indonesian creative practitioners and connect them with global opportunities.

About Mega Arts and Cultural Events (ACE) Fund

The Culture, Sports and Tourism Bureau of the Hong Kong Special Administrative Region Government sets up the Mega ACE Fund to attract and support international or large-scale arts and cultural events which bring significant arts, cultural or economic values and can be recurrent and anchored in Hong Kong, or events which can bring exceptionally significant arts or cultural merit, as well as publicity and image building values to Hong Kong as an arts and cultural hub with a view to contributing to Hong Kong’s development into an arts and cultural metropolis as well as a tourist destination, providing development opportunities for the arts, cultural and creative sectors, and facilitating arts and cultural exchange.

1...833834835...6,591Page 834 of 6,591